Washington Biotechnology and Biomedical Association

Washington Biotechnology and Biomedical Association

Directors
Accessed December 2007:


 * James Bianco, M.D., President & CEO, Cell Therapeutics, Inc.
 * Anthony Bonanzino, President and CEO, Hollister-Stier Laboratories LLC
 * Bruce L. A. Carter, Ph.D., President and CEO, ZymoGenetics, Inc.
 * Thomas Clement, President & CEO, Pathway Medical Technologies, Inc.
 * Rob Derry, Investment Advisor, Silicon Valley Bank
 * Ed Drosdick, Partner, Moss Adams LLP
 * Christopher J. Elias, M.D., MPH, President, PATH - Program for Appropriate Technology in Health
 * Donald Elmer, Managing General Partner, Pacific Horizon Ventures
 * Beth Etscheid, Ph.D., Director of Licensing, Washington Research Foundation
 * Jack Faris, Ph.D., President, Washington Biotechnology & Biomedical Association
 * H. Perry Fell, Ph.D., President & CEO, NanoString Technologies
 * Alan D. Frazier, Founder and Managing Partner, Frazier Healthcare Ventures
 * Alan Fuhrman, Senior Vice President & CFO, Sonus Pharmaceuticals, Inc.
 * Linda Gainer, Vice President, External Relations and Communications, Fred Hutchinson Cancer Research Center
 * Brett V. Gaspers, Managing Director, Objective Insights
 * Mitchell H. Gold, CEO, Dendreon Corporation
 * James Gore, Vice President, Pacific Northwest Research Institute (PNRI)
 * Stephen M. Graham, Managing Partner, Orrick, Herrington & Sutcliffe LLP
 * Kayreen Handley, Partner, KPMG LLP
 * Douglas R. Hansmann, General Manager, EKOS Corporation
 * John F. Harris, President & CEO, NeuroVista Corporation
 * Karen Hedine, President & CEO, Micronics, Inc.
 * James B. Hendricks, PhD, President, Seattle Children's Hospital Research Institute
 * John Hinson, President & CEO, Cardiac Science Corporation
 * John Gardner, Vice President for Economic Development and Extension, WSU
 * Allan Jones, Ph.D., Chief Scientific Officer, Allen Institute for Brain Science
 * Jim Karkanias, Senior Director of Applied Research and Technology, Health Solutions Group, Microsoft
 * Kevin F. Kelly, Shareholder, Heller Ehrman Attorneys
 * Deborah Kessler, Chief Operating Officer, Acucela
 * Bill Kimmerly, PhD, Director, Facilities for Systems Biology & Applications, Pacific Northwest National Laboratory
 * Rick Klausner, Partner, The Column Group
 * Deborah Knutson, President, EDC of Snohomish County
 * Michael Kranda, Director of Biotechnology Venture Investments, Vulcan Inc.
 * Thong W. Le, Managing Director, WRF Capital
 * Bill Lewis, President & CEO, Lease Crutcher Lewis
 * Jim Lisbakken, Partner & Chair of Life Sciences Practice Group, Perkins Coie LLP
 * Carl Mackleit, Senior Tax Manager, Ernst & Young LLP
 * Tim Martin, Director of State Government Relations, Amgen
 * Margaret McCormick, Ph.D., Partner, Integra Ventures
 * A. Bruce Montgomery, M.D., Senior VP, Gilead Respiratory Therapeutics
 * Jack Nagan, Executive Director Benaroya Research Institute at Virginia Mason and VP Research, Virginia Mason Medical Center
 * H. Stewart Parker, President & CEO, Targeted Genetics Corporation
 * Jens Quistgaard, President & CEO, Liposonix, Inc.
 * Erick Rabins, Vice President, Allied Minds, Inc.
 * J. Thomas Ranken, Co-Founder and CEO, VizX Labs, LLC
 * Gregory Sessler, Chief Financial Officer, Spiration, Inc.
 * James A. Severson, Ph.D., Vice Provost, Intellectual Property & Technology Transfer, UW TechTransfer
 * Clay B. Siegall, Ph.D., President & CEO, Seattle Genetics, Inc.
 * John Steel, Partner, DLA Piper US LLP
 * Terry Sweeney, Senior Vice President Quality & Regulatory Affairs, Philips Ultrasound
 * Peter Thompson, M.D., President & CEO, Director, Trubion Pharmaceuticals, Inc.
 * Carl Weissman, President & CEO, Accelerator Corporation
 * Michael Wiley, MBA Biotech Club, University of Washington
 * Susan Wray Spraitzar, DDS, JD, Senior Director of Regulatory & Intellectual Property, Light Sciences Oncology, Inc.

Contact

 * Web: http://www.wabio.com